These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19642423)

  • 21. Field experiences in testing membrane filter integrity by the forward Flow Test method.
    Cole JC; Pauli WA
    Bull Parenter Drug Assoc; 1975; 29(6):296-304. PubMed ID: 1203607
    [No Abstract]   [Full Text] [Related]  

  • 22. Sorption of bacterial endotoxin and retention of bacteria by positively charged membrane filters.
    van Doorne H
    J Parenter Sci Technol; 1993; 47(5):192-8. PubMed ID: 8263658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in hospital sterilizing processes. Revision to Health Technical Memorandum 10.
    Arrowsmith LW
    Hosp Eng; 1979; 33(1):18-21. PubMed ID: 10240093
    [No Abstract]   [Full Text] [Related]  

  • 24. Filtration solutions.
    Med Device Technol; 2006 Jun; 17(5):48-9. PubMed ID: 16903393
    [No Abstract]   [Full Text] [Related]  

  • 25. Preuse/Poststerilization Integrity Testing (PUPSIT): To Do or Not to Do?
    Gupta VS; Jindal J; Gupta A; Gupta NK
    PDA J Pharm Sci Technol; 2020; 74(3):301-308. PubMed ID: 31732690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane-filter bubble-point test.
    Newton DW
    Am J Health Syst Pharm; 2008 Dec; 65(23):2210, 2212; author reply 2212. PubMed ID: 19020184
    [No Abstract]   [Full Text] [Related]  

  • 27. [End filtration in infusion therapy].
    Zimmermann K
    Krankenpfl Soins Infirm; 2015; 108(11):34-5. PubMed ID: 26677656
    [No Abstract]   [Full Text] [Related]  

  • 28. Application of membrane filtration for removal of diminutive bioburden organisms in pharmaceutical products and processes.
    Sundaram S; Auriemma M; Howard G; Brandwein H; Leo F
    PDA J Pharm Sci Technol; 1999; 53(4):186-201. PubMed ID: 10754712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of endotoxin retention by adsorptive-based filtration media.
    O'Brien TP; Conway R; Chen HL; Buckland K
    PDA J Pharm Sci Technol; 2007; 61(2):75-87. PubMed ID: 17479715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Devonport incident, the Clothier Report, and related matters--30 years on.
    Matthews BR
    PDA J Pharm Sci Technol; 2002; 56(3):137-49. PubMed ID: 12109334
    [No Abstract]   [Full Text] [Related]  

  • 31. Data Mining to Determine the Influence of Fluid Properties on the Integrity Test Values.
    Thome B; Joseph B; Dassu D; Gaerke J; McBurnie L; Dixit M; Stering M; Tomlinson S; Mills S; Ferrante S; Weitzmann C
    PDA J Pharm Sci Technol; 2020; 74(5):524-562. PubMed ID: 32467178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New particle counter for nondestructive monitoring of parenterals.
    Porter MC
    Bull Parenter Drug Assoc; 1975; 29(4):169-82. PubMed ID: 1131461
    [No Abstract]   [Full Text] [Related]  

  • 33. [The microbiology of medication: concept - elaboration - control].
    Lagodsky H; Blanchard JC; Jandard M; Migne J
    Biol Med (1971); 1973 Dec; 2(2):141-56. PubMed ID: 4807318
    [No Abstract]   [Full Text] [Related]  

  • 34. Test Process and Results of Potential Masking of Sterilizing-Grade Filters.
    Ferrante S; McBurnie L; Dixit M; Joseph B; Jornitz M
    PDA J Pharm Sci Technol; 2020; 74(5):509-523. PubMed ID: 32467175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of anti-viral filters.
    Hughes B; Bradburne A; Sheppard A; Young D
    Dev Biol Stand; 1996; 88():91-8. PubMed ID: 9119168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Filtration of liquids using cellulose-based depth filters. Technical Report no 45.
    PDA J Pharm Sci Technol; 2008; 62(2 Suppl TR45):2-35. PubMed ID: 18649825
    [No Abstract]   [Full Text] [Related]  

  • 37. Sterile Filtration of Highly Concentrated Protein Formulations: Impact of Protein Concentration, Formulation Composition, and Filter Material.
    Allmendinger A; Mueller R; Huwyler J; Mahler HC; Fischer S
    J Pharm Sci; 2015 Oct; 104(10):3319-29. PubMed ID: 26149748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total organic carbon (VCSN and VWP) and HPLC analysis for cleaning validation in a pharmaceutical pilot plant.
    Queralt M; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Miñarro M; Ticó JR
    PDA J Pharm Sci Technol; 2009; 63(1):42-57. PubMed ID: 19455941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aluminum contamination of parenteral nutrition fluids.
    Mirtallo JM
    JPEN J Parenter Enteral Nutr; 2010; 34(3):346-7. PubMed ID: 20467017
    [No Abstract]   [Full Text] [Related]  

  • 40. [A device for filtering sterile drug solutions].
    Khrapovitskiĭ KI; Berezniuk MA
    Voen Med Zh; 1990 Nov; (11):58-9. PubMed ID: 2077722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.